Highly active human pharmaceuticals in aquatic systems: A concept for their identification based on their mode of action

Aquatic Toxicology

Volumn 96, Issue 3, 2010, Pages 167-181

  Christen, Verena ^a   Hickmann, Silke ^b   Rechenberg, Bettina ^b   Fent, Karl ^a,c  

^a UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

^b UMWELTBUNDESAMT   (Germany)

^c ETH ZURICH   (Switzerland)

Author keywords

Ecotoxicology; Effects of pharmaceuticals; EMEA guideline; Mode of action concept; Pharmaceuticals in the environment; Review

Indexed keywords

CLOTRIMAZOLE; DIAZEPAM; DICLOFENAC; EQUILENIN; ETHINYLESTRADIOL; FLUOXETINE; LEVONORGESTREL; METHYLTESTOSTERONE; METOPROLOL; PARACETAMOL; PROPRANOLOL; TAMOXIFEN; TRENBOLONE; TRICLOSAN;

AQUATIC ECOSYSTEM; CONCEPTUAL FRAMEWORK; DRUG; ECOTOXICOLOGY; ENVIRONMENTAL RISK; ESTIMATION METHOD; GUIDELINE; LABORATORY METHOD; MODELING; NONTARGET ORGANISM; RISK ASSESSMENT; TOXICITY;

AQUATIC ENVIRONMENT; CHEMICAL WASTE; CONCENTRATION (PARAMETERS); CONTAMINATED FISH; DRUG BLOOD LEVEL; DRUG IDENTIFICATION; DRUG INDUSTRY; DRUG MECHANISM; DRUG TARGETING; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT ASSESSMENT; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; POLLUTION TRANSPORT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; SEQUENCE HOMOLOGY; TOXICITY TESTING; WATER CONTAMINATION; WATER SAMPLING;

ANIMALS; ENVIRONMENTAL MONITORING; FRESH WATER; HUMANS; PRESCRIPTION DRUGS; WATER POLLUTANTS, CHEMICAL;

EQUIDAE;

EID: 75449087350     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2009.11.021     Document Type: Review

References (71)

1. Ankley G.T., Kahl M.D., Jensen K.M., Hornung M.W., Korte J.J., Makynen E.A., and Leino R.L. Evaluation of the aromatase inhibitor fadrozole in a short-term reproduction assay with the fathead minnow (Pimephales promelas). Toxicol. Sci. 67 (2002) 121-130
2. Ankley G.T., Brooks B.W., Huggett D.B., and Sumpter J.P. Repeating history: pharmaceuticals in the environment. Environ. Sci. Technol. 41 (2007) 8211-8217
3. Bayley M., Junge M., and Baatrup E. Exposure of juvenile guppies to three antiandrogens causes demasculinization and a reduced sperm count in adult males. Aquat. Toxicol. 56 (2002) 227-239
4. Bjerregaard P., Hansen P.R., Larsen K.J., Erratico C., Korsgaard B., and Holbech H. Vitellogenin as a biomarker for estrogenic effects in brown trout, Salmo trutta: laboratory and field investigations. Environ. Toxicol. Chem. 11 (2008) 2387-2396
5. Brain R.A., Johnson D.J., Richards S.M., Sanderson H., Sibley P.K., and Solomon K.R. Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day staticrenewal test. Environ. Toxicol. Chem. 23 (2004) 371-382
6. Booth B. In the mix: equine estrogens used in HRT. Environ. Sci. Technol. 43 (2009) 3404
7. Brambilla G., and Martelli A. Genotoxicity and carcinogenicity studies of antihypertensive agents. Mutat. Res. 612 (2006) 115-149
8. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., and Stanley J.K. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 142 (2003) 169-183
9. Canesi L., Lorusso L.C., Ciacci C., Betti M., Regoli F., Poiana G., Gallo G., and Marcomini A. Effects of blood lipid lowering pharmaceuticals (bezafibrate and gemfibrozil) on immune and digestive gland functions of the bivalve mollusc, Mytilus galloprovincialis. Chemosphere 69 (2007) 994-1002
10. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change. Environ. Health Perspect. 107 (1999) 907-938
11. Debernard S., Rossignol F., and Couillaud F. The HMG-CoA reductase inhibitor fluvastatin inhibits insect juvenile hormone biosynthesis. Gen. Comp. Endocrinol. 95 (1994) 92-98
12. Escher B.I., Bramaz N., Richter M.J., and Lienert J. Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environ. Sci. Technol. 40 (2006) 7402-7408
13. Escriva H., Safi R., Hanni C., Langlois M.C., Saumitou-Laprade P., Stehelin D., Capron A., Pierce R., and Laudet V. Ligand binding was acquired during evolution of nuclear receptors. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6803-6808
14. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76 (2006) 122-159
15. Ferrari B., Paxeus N., Lo Giudice R., Pollio A., and Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Saf. 55 (2003) 359-370
16. Ferrari B., Mons R., Vollat B., Fraysse B., Paxeus N., Lo Giudice R., Pollio A., and Garric J. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ. Toxicol. Chem. 23 (2004) 1344-1354
17. Foran C.M., Weston J., Slattery M., Brooks B.W., and Huggett D.B. Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch. Environ. Contam. Toxicol. 46 (2004) 511-517
18. Fujioka J. Effects of hormone treatments and temperature on sex-reversal of Nigorobuna Carassius carassius grandoculis. Fish Sci. 68 (2002) 889-893
19. Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. CPMP/SWP/4447/00, 2006. European Medicines Agency.
20. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., and Larsson D.G. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 42 (2008) 5807-5813
21. Halling-Sorensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lutzhoft H.C., and Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36 (1998) 357-393
22. Henry T.B., Kwon J.W., Armbrust K.L., and Black M.C. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ. Toxicol. Chem. 23 (2004) 2229-2233
23. Holbech H., Kinnberg K., Petersen G.I., Jackson P., Hylland K., Norrgren L., and Bjerregaard P. Detection of endocrine disrupters: evaluation of a Fish Sexual Development Test (FSDT). Comp. Biochem. Physiol. C Toxicol. Pharmacol. 144 (2006) 57-66
24. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., and Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (B-blockers) on aquatic organisms. Arch. Environ. Contam. Toxicol. 43 (2002) 229-235
25. Huggett D.B., Cook J.C., Ericson J.F., and Williams R.T. A Theoretical Model for Utilizing Mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum. Ecol. Risk Assess. 9 (2003) 1789-1799
26. Huschek G., Hansen P.D., Maurer H.H., Krengel D., and Kayser A. Environmental risk assessment of medicinal products for human use according to European Commission recommendations. Environ. Toxicol. 19 (2004) 226-240
27. Hutchinson T.H., Yokota H., Hagino S., and Ozato K. Development of fish tests for endocrine disruptors. Pure Appl. Chem. 75 (2003) 2343-2353
28. Ikeuchia T., Todob T., Kobayashia T., and Nagahama Y. Two subtypes of androgen and progestogen receptors in fish testes. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 129 (2001) 449-455
29. Jobling S., Casey D., Rodgers-Gray T., Oehlmann J., Schulte-Oehlmann U., Pawlowski S., Baunbeck T., Turner A.P., and Tyler C.R. Comparative responses of molluscs and fish to environmental estrogens and an estrogenic effluent. Aquat. Toxicol. 65 (2003) 205-220
30. Johnson A.C., Williams R.J., and Matthiessen P. The potential steroid hormone contribution of farm animals to freshwaters, the United Kingdom as a case study. Sci. Total Environ. 362 (2006) 166-178
31. Jones O.A., Voulvoulis N., and Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 36 (2002) 5013-5022
32. Katsu Y., Hinago M., Sone K., Urushitani H., Guillette Jr. L.J., and Iguchi T. In vitro assessment of transcriptional activation of the estrogen and androgen receptors of mosquitofish, Gambusia affinis. Mol. Cell Endocrinol. 276 (2007) 10-17
33. Kawakami Y., Tanda M., Adachi S., and Yamauchi K. cDNA cloning of thyroid hormone receptor betas from the conger eel, Conger myriaster. Gen. Comp. Endocrinol. 131 (2003) 232-240
34. Kay P., Blackwell P.A., and Boxall A.B. A lysimeter experiment to investigate the leaching of veterinary antibiotics through a clay soil and comparison with field data. Environ. Pollut. 134 (2005) 333-341
35. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36 (2002) 1202-1211
36. Köpf W. Effects of endocrine substances in bioassays with aquatic organisms. Presentation at the 50th Seminar of the Bavarian Association for Water Supply (1995)
37. Länge R., Hutchinson T.H., Croudace C.P., Siegmund F., Schweinfurth H., Hampe P., Panter G.H., and Sumpter J.P. Effects of the synthetic estrogen 17 alpha-ethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 20 (2001) 1216-1227
38. Lange A., Katsu Y., Ichikawa R., Paull G.C., Chidgey L.L., Coe T.S., Iguchi T., and Tyler C.R. Altered sexual development in roach (Rutilus rutilus) exposed to environmental concentrations of the pharmaceutical 17alpha-ethinylestradiol and associated expression dynamics of aromatases and estrogen receptors. Toxicol. Sci. 106 (2008) 113-123
39. Lange A., Paull G.C., Coe T.S., Katsu Y., Urushitani H., Iguchi T., and Tyler C.R. Sexual reprogramming and estrogenic sensitization in wild fish exposed to ethinylestradiol. Environ. Sci. Technol. 43 (2009) 1219-1225
40. Lassiter C.S., Kelley B., and Linney E. Genomic structure and embryonic expression of estrogen receptor βa (ERβa) in zebrafish (Danio rerio). Gene 299 (2002) 141-151
41. Menuet A., Pellegrini E., Anglade I., Blaise O., Laudet V., Kah O., and Pakdel F. Molecular characterization of three estrogen receptor forms in zebrafish: binding characteristics, transactivation properties, and tissue distributions. Biol. Reprod. 66 (2002) 1881-1892
42. Muster W., Breidenbach A., Fischer H., Kirchner S., Müller L., and Pähler A. Computational toxicology in drug development. Drug Discov. Today 13 (2008) 303-310
43. Navarro I., Leibush B., Moon T.W., Plisetskaya E.M., Banos N., Mendez E., Planas J.V., and Gutierrez J. Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 122 (1999) 137-153
44. Nickerson J.G., Dugan S.G., Drouin G., and Moon T.W. A putative beta2-adrenoceptor from the rainbow trout (Oncorhynuchus mykiss). Molecular characterization and pharmacology. Eur. J. Biochem. 268 (2001) 6465-6472
45. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., Shivaprasad H.L., Ahmed S., Chaudhry M.J., Arshad M., Mahmood S., Ali A., and Khan A.A. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427 (2004) 630-633
46. Oba Y., Hirai T., Yoshiura Y., Kobayashi T., and Nagahama Y. Cloning, functional characterization, and expression of thyrotropin receptors in the thyroid of amago salmon (Oncorhynchus rhodurus). Biochem. Biophys. Res. Commun. 276 (2000) 258-263
47. Owen S.T., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J., Winter M.J., and Sumpter J. Comparative physiology, pharmacology and toxicology of β-blockers: mammals versus fish. Aquat. Toxicol. 82 (2007) 145-162
48. Pascoe D., Karntanut W., and Muller C.T. Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris. Chemosphere 51 (2003) 521-528
49. Paterson G., and Metcalfe C.D. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 74 (2008) 125-130
50. Porsbring T., Blanck H., Tjellström H., and Backhaus T. Toxicity of the pharmaceutical clotrimazole to marine microalgal communities. Aquat. Toxicol. 91 (2009) 203-211
51. Prunet P., Sturm A., and Milla S. Multiple corticosteroid receptors in fish: from old ideas to new concepts. Gen. Comp. Endocrinol. 147 (2006) 17-23
52. Raingeard D., Cancio I., and Cajaraville M.P. Cloning and expression pattern of peroxisome proliferator-activated receptor alpha in the thicklip grey mullet Chelon labrosus. Mar. Environ. Res. 62 Suppl. (2006) S113-S117
53. Richardson M.L., and Bowron J.M. The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol. 37 (1985) 1-12
54. Runnalls T.J., Hala D.N., and Sumpter J.P. Preliminary studies into the effects of the human pharmaceutical clofibric acid on sperm parameters in adult fathead minnow. Aquat. Toxicol. 84 1 (2007) 111-118
55. Ruyter B., Andersen O., Dehli A., Ostlund Farrants A.K., Gjøen T., and Thomassen M.S. Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids. Biochim. Biophys. Acta 1348 (1997) 331-338
56. Schulte-Oehlmann U., Oetken M., Bachmann J., and Oehlmann J. Effects of ethinylestradiol and methyltestosterone in prosbranch snails. In: Kümmerer K. (Ed). Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. 2nd edition (2004), Springer-Verlag, Berlin, Heidelberg 233-247
57. Sebire M., Allen Y., Bersuder P., and Katsiadaki I. The model anti-androgen flutamide suppresses the expression of typical male stickleback reproductive behaviour. Aquat. Toxicol. 90 (2008) 37-47
58. Shved N., Berishvili G., Baroiller J.F., Segner H., and Reinecke M. Environmentally relevant concentrations of 17alpha-ethinylestradiol (EE2) interfere with the growth hormone (GH)/insulin-like growth factor (IGF)-I system in developing bony fish. Toxicol. Sci. 106 (2008) 93-102
59. Tchoudakova A., Pathak S., and Callard G.V. Molecular cloning of an estrogen receptor beta subtype from the goldfish, Carassius auratus. Gen. Comp. Endocrinol. 113 (1999) 388-400
60. Todo T., Adachi S., and Yamauchi K. Molecular cloning and characterization of Japanese eel estrogen receptor cDNA. Mol. Cell Endocrinol. 17 (1996) 37-45
61. Tyler C.R., Filby A.L., Bickley L.K., Cumming R.I., Gibson R., Labadie P., Katsu Y., Liney K.E., Shears J.A., Silva-Castro V., Urushitani H., Lange A., Winter M.J., Iguchi T., and Hill E.M. Environmental health impacts of equine estrogens derived from hormone replacement therapy. Environ. Sci. Technol. 43 (2009) 3897-3904
62. Uckun F.M., Tibbles H.E., Venkatachalam T.K., and Erbeck D. In vivo pharmacokinetics, metabolism, toxicity, and anti-HIV activity of N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)]thiourea (HI-443), a potent non-nucleoside inhibitor of HIV reverse transcriptase. Arzneimittelforschung 57 (2007) 483-496
63. Veldhoen N., Skirrow R.C., Osachoff H., Wigmore H., Clapson D.J., Gunderson M.P., Van Aggelen G., and Helbing C.C. The bactericidal agent triclosan modulates thyroid hormone38 associated gene expression and disrupts postembryonic anuran development. Aquat. Toxicol. 80 (2006) 217-227
64. Wang Y., Guo B., Zhang F., Yao H., Miao Z., and Tang K. Molecular cloning and functional analysis of the gene encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase from hazel (Corylus avellana L. Gasaway). J. Biochem. Mol. Biol. 40 (2007) 861-869
65. Weiler I.J., Lew D., and Shapiro D.J. The Xenopus laevis estrogen receptor: sequence homology with human and avian receptors and identification of multiple estrogen receptor messenger ribonucleic acids. Mol. Endocrinol. 5 (1987) 355-362
66. Williams T.D., Caunter J.E., Lillicrap A.D., Hutchinson T.H., Gillings E.G., and Duffell S. Evaluation of the reproductive effects of tamoxifen citrate in partial and full life-cycle studies using fathead minnows (Pimephales promelas). Environ. Toxicol. Chem. 26 (2007) 695-707
67. Wilson V.S., Cardon M.C., Thornton J., Korte J.J., Ankley G.T., Welch J., Gray L.E., and Hartig P.C. Cloning and in vitro expression and characterization of the androgen receptor and isolation of estrogen receptor alpha from the fathead Minnow (Pimephales promelas). Environ. Sci. Technol. 38 (2004) 6314-6321
68. Winter M.J., Lillicrap A.D., Caunter J.E., Schaffner C., Alder A.C., Ramil M., Ternes T.A., Giltrow E., Sumpter J.P., and Hutchinson T.H. Defining the chronic impacts of atenolol on embryo-larval development and reproduction in the fathead minnow (Pimephales promelas). Aquat. Toxicol. 86 (2008) 361-369
69. Xu H., Yang J., Wang Y., Jiang Q., Chen H., and Song H. Exposure to 17alpha-ethynylestradiol impairs reproductive functions of both male and female zebrafish (Danio rerio). Aquat. Toxicol. 88 (2008) 1-8
70. Zhang Z., Diener R.M., and Lipman J.M. Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats. Int. J. Toxicol. 25 (2006) 285-294
71. Zeilinger J., Steger-Hartmann T., Maser E., Goller S., Vonk R., and Länge R. Effects of synthetic gestagenes on fish reproduction. Environ. Toxicol. Chem. 28 (2009) 2663-2670